Medicare Enrolled

Dr. Lynne Perry-Bottinger, M.D.

Interventional Cardiology · New Rochelle, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
140A LOCKWOOD AVE, New Rochelle, NY 10801
9145767577
In practice since 2005 (20 years)
NPI: 1568448314 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Perry-Bottinger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Perry-Bottinger? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Perry-Bottinger

Dr. Lynne Perry-Bottinger is an interventional cardiology specialist in New Rochelle, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Perry-Bottinger performed 482 Medicare services across 433 unique beneficiaries.

Between the years covered by Open Payments, Dr. Perry-Bottinger received a total of $16,733 from 37 pharmaceutical and/or device companies across 317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Perry-Bottinger is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 482 Medicare services $16,733 industry payments

Medicare Practice Summary

Medicare Utilization ↗
482
Medicare services
Bottom 26% in NY for interventional cardiology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
433
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~24 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
222 $13 $108
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
146 $101 $200
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
71 $159 $275
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
16 $73 $150
Continuous external EKG monitoring, 8-15 days
This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days.
14 $12 $150
New patient office visit, complex (60-74 min) 13 $173 $300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,733
Total received (2018-2024)
Avg $2,390/year across 7 years
Top 29% in NY for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
317
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,644 (93.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$599 (3.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$489 (2.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,009
2023
$3,607
2022
$1,760
2021
$1,586
2020
$1,452
2019
$2,274
2018
$4,044

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$773
Kiniksa Pharmaceuticals International, plc
$250
Abbott Laboratories
$170
Amgen Inc.
$150
Novo Nordisk Inc
$145
Lilly USA, LLC
$141
Actelion Pharmaceuticals US, Inc.
$109
PROGENICS PHARMACEUTICALS, INC.
$66
Esperion Therapeutics, Inc.
$62
PFIZER INC.
$56
SCPHARMACEUTICALS INC.
$52
Merck Sharp & Dohme LLC
$18
Kowa Pharmaceuticals America, Inc.
$16
Top 3 companies account for 59.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,787
Medtronic, Inc.
$1,659
Amarin Pharma Inc.
$1,410
E.R. Squibb & Sons, L.L.C.
$1,299
Amgen Inc.
$1,143
Janssen Pharmaceuticals, Inc
$1,134
Actelion Pharmaceuticals US, Inc.
$1,059
PFIZER INC.
$903
Novo Nordisk Inc
$852
Novartis Pharmaceuticals Corporation
$809
Siemens Medical Solutions USA, Inc.
$599
Astellas Pharma US Inc
$509
Esperion Therapeutics, Inc.
$469
Kowa Pharmaceuticals America, Inc.
$458
Boston Scientific Corporation
$284
Boehringer Ingelheim Pharmaceuticals, Inc.
$260
Kiniksa Pharmaceuticals International, plc
$250
Merck Sharp & Dohme LLC
$174
Abbott Laboratories
$170
ABIOMED
$148
BOSTON SCIENTIFIC CORPORATION
$148
Lilly USA, LLC
$141
ViiV Healthcare Company
$125
ARALEZ PHARMACEUTICALS US INC.
$125
Progenics Pharmaceuticals, Inc.
$122
AbbVie, Inc.
$121
PORTOLA PHARMACEUTICALS, INC.
$92
bioMerieux Inc
$75
Tactile Systems Technology Inc
$68
PROGENICS PHARMACEUTICALS, INC.
$66
AKRIMAX PHARMACEUTICALS, LLC
$54
SCPHARMACEUTICALS INC.
$52
Baxter Healthcare
$45
Gilead Sciences, Inc.
$45
Bardy Diagnostics, Inc.
$30
Medtronic Vascular, Inc.
$25
Merck Sharp & Dohme Corporation
$24
Top 3 companies account for 29.0% of all-time payments
Associated products mentioned in payments ›
ABRYSVO · AIRSUPRA · ANDEXXA · APRETUDE · Arcalyst · BREZTRI · BRILINTA · CAMZYOS · CHANTIX · Carnation Ambulatory Monitor · Corlanor · ELIQUIS · ENTRESTO · FARXIGA · FLEXITOUCH · FREESTYLE LIBRE 3 · FUROSCIX · Hillrom - Carnation Ambulatory Monitor · Humira · Impella · JARDIANCE · LEXISCAN · LINQ II · LIVALO · Livalo · NEXLETOL · NEXLIZET · Nitromist · OPSUMIT · OPSUMIT MACITENTAN · Ozempic · PYLARIFY · Repatha · Reveal LINQ · SC2000 · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WINREVAIR · XARELTO · ZEPBOUND · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an interventional cardiology specialist in New Rochelle?
Compare interventional cardiologists in the New Rochelle area by procedure volume, costs, and industry payment transparency.
Browse interventional cardiologists nearby

Geographic Context

Interventional cardiologists within 10 mi
169
Per 100K population
17.0
County median income
$118,411
Nearest hospital
MONTEFIORE MOUNT VERNON HOSPITAL
2.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Perry-Bottinger is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Perry-Bottinger experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Perry-Bottinger performed 222 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Perry-Bottinger receive payments from pharmaceutical companies?
Yes. Dr. Perry-Bottinger received a total of $16,733 from 37 companies across 317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Perry-Bottinger's costs compare to other interventional cardiologists in New Rochelle?
Dr. Perry-Bottinger's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Perry-Bottinger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →